Physician profile
David Ross
NPI 1366544652
$6,341.28
in general payments reported to CMS, 2019-2025
21 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,196 · 2020: $1,108 · 2021: $230 · 2022: $641 · 2023: $489 · 2024: $644 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,147 · Entertainment: $19.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,147.21 |
| Entertainment | $19.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,108.43 | 2019-2025 | Total30, Precision 1, Precision7 |
| Johnson & Johnson Vision Care, INC. | $980.73 | 2019-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $419.42 | 2024-2025 | Xdemvy |
| Coopervision INC. | $245.86 | 2019-2024 | Myday Contact Lens, Onefit Contact Lens |
| Oyster Point Pharma, INC. | $192.59 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $189.46 | 2023-2025 | Miebo, Xiidra, Infuse |
| Novartis Pharmaceuticals Corporation | $174.64 | 2019-2023 | |
| Allergan, INC. | $162.06 | 2019-2022 | |
| Abb Con-Cise Optical Group LLC | $151.63 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Sun Pharmaceutical Industries INC. | $143.89 | 2022-2025 | |
| Rxsight INC | $137.56 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $117.38 | 2025 | Tecnis Iol |
| Aerie Pharmaceuticals, INC. | $111.35 | 2019 | |
| Ivantis, INC | $88.24 | 2020 | |
| Biotissue Holdings INC. | $20.06 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $19.44 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $18.13 | 2025 | Cirrus Hd-Oct |
| Menicon America INC | $17.12 | 2019 | |
| Shire North American Group INC | $16.56 | 2019 | |
| Sight Sciences, INC. | $13.97 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.